Home / Business and Economy / Tech Giants Tesla and Palantir Ride AI Wave to Mega-Cap Gains

Tech Giants Tesla and Palantir Ride AI Wave to Mega-Cap Gains

Summary

  • Tesla and Palantir lead mega-cap gains on AI developments
  • Gilead Sciences jumps 8% on HIV treatment momentum
  • Natera surges 14% on revenue beat
Tech Giants Tesla and Palantir Ride AI Wave to Mega-Cap Gains

In the latest market update on August 8th, 2025, the tech sector has been the driving force behind the day's impressive gains. Leading the charge are two industry giants, Tesla and Palantir Technologies, which have seen their share prices soar on the back of AI-related developments.

Tesla, the electric vehicle pioneer, has added more than 3% to its value, continuing its momentum in the AI space. Palantir, the data analytics firm, has also seen a nearly 3% rise after its FedStart program, designed to help software companies meet federal compliance, welcomed a new participant, Unstructured.

The broader market has also been buoyed by these AI-driven gains, with Alphabet, the parent company of Google, also seeing an impressive 2% increase.

Beyond the tech sector, the biotech industry has also been a standout performer. Gilead Sciences, a leading pharmaceutical company, has jumped 8% following a Buy rating upgrade from Truist Securities for its HIV treatment. Meanwhile, Natera, a genetic testing firm, has surged 14% on the back of a revenue beat.

Other notable movers include Doximity, GenOn Energy, and Sotera Health, which have all seen double-digit percentage gains ranging from 11% to 20%.

As the market continues to react to the latest developments, investors will be closely watching the performance of these companies and the broader AI-driven trends shaping the industry.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.

FAQ

Tesla's stock has risen due to advancements in artificial intelligence (AI) technology, which have fueled the company's growth and investor interest.
Palantir's FedStart program, which helps software companies meet federal compliance, has seen a new participant, Unstructured, join the program, contributing to a nearly 3% rise in Palantir's stock.
Natera, a genetic testing firm, has seen a 14% surge in its stock price due to a revenue beat, indicating strong financial performance and investor confidence in the company.

Read more news on